J
J-F Colombel
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 83
Citations - 4808
J-F Colombel is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Inflammatory bowel disease & Population. The author has an hindex of 19, co-authored 83 publications receiving 4249 citations. Previous affiliations of J-F Colombel include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
TL;DR: Key issues that have emerged from discussions of the Montreal Working Party are highlighted and the relevance to clinical practice and research activities are highlighted.
Journal ArticleDOI
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
Spl Travis,Eduard F. Stange,Marc Lémann,Tom Øresland,Yehuda Chowers,Alastair Forbes,G. D'Haens,G Kitis,Antoine Cortot,Cosimo Prantera,P. Marteau,J-F Colombel,Paolo Gionchetti,Yoram Bouhnik,Emmanuel Tiret,J Kroesen,M Starlinger,Neil Mortensen +17 more
TL;DR: This second section of the European Crohn’s and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery.
Journal ArticleDOI
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn’s Disease
Gautier Hoarau,Pranab K. Mukherjee,Corinne Gower-Rousseau,Chris Hager,Jyotsna Chandra,Mauricio Retuerto,Christel Neut,Severine Vermeire,Jose C. Clemente,J-F Colombel,J-F Colombel,Hisashi Fujioka,Daniel Poulain,Boualem Sendid,Mahmoud A. Ghannoum +14 more
TL;DR: The gut bacterial microbiota (bacteriome) and fungal community (mycobiome) in multiplex families with CD and healthy relatives and the microbial interactions leading to dysbiosis in CD are characterized to provide insight into the roles of bacteria and fungi in CD and may lead to the development of novel treatment approaches and diagnostic assays.
Journal ArticleDOI
Opposite evolution in incidence of Crohn’s disease and ulcerative colitis in Northern France (1988–1999)
Florence Molinie,Corinne Gower-Rousseau,Thierry Yzet,Véronique Merle,Bruno Grandbastien,Marti R,Eric Lerebours,J-L Dupas,J-F Colombel,J-L Salomez,Antoine Cortot +10 more
TL;DR: The incidence of CD increased by 23% in 12 years in Northern France while that of UC decreased by 17% during the same period, indicating that some factors which influence IBD frequency (in both directions) are still at work in this area of Europe.
Journal ArticleDOI
Serum calprotectin as a biomarker for Crohn's disease.
Marie-Alice Meuwis,Gwenola Vernier-Massouille,Jean-Charles Grimaud,Yoram Bouhnik,David Laharie,Eric Piver,Laurence Seidel,J-F Colombel,Edouard Louis +8 more
TL;DR: As a CD biomarker, serum calprotectin has a similar profile as hsCRP and is also complementary to fecal cal Protectin and hs CRP for prediction of relapse after infliximab withdrawal.